Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics to predict drug response.

G I Adam1, R Reneland, M Andersson

  • 1Eurona Medical AB, Uppsala, Sweden. gail.adam@eurona.se

Pharmacogenomics
|March 22, 2001
PubMed
Summary

Pharmacogenomics aims to personalize medicine by predicting drug response, improving patient outcomes, and reducing costs. While promising, widespread clinical adoption of pharmacogenomic tests is still emerging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for anastomotic leakage after anterior resection of the rectum.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2004
Same author

Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure.

The European respiratory journal·2004
Same author

Surface attachment of nanoparticles using oligonucleotides.

Colloids and surfaces. B, Biointerfaces·2004
Same author

Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2004
Same author

Building materials as a source of PCB pollution in Bergen, Norway.

The Science of the total environment·2004
Same author

Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study.

European journal of cancer (Oxford, England : 1990)·2004

Area of Science:

  • Pharmacogenomics
  • Personalized Medicine
  • Drug Development

Background:

  • Pharmacogenomics offers potential to enhance healthcare by tailoring drug treatments to individual patients.
  • This personalized approach aims to improve therapeutic efficacy and minimize adverse drug reactions.

Purpose of the Study:

  • To explore the theoretical promise and practical application of pharmacogenomics in healthcare.
  • To assess the current state and future impact of pharmacogenomic tests in clinical practice and pharmaceutical development.

Main Methods:

  • Review of theoretical frameworks and proof-of-concept studies in pharmacogenomics.
  • Analysis of the role of pharmacogenomic tests in clinical trial design and pharmaceutical R&D.

Main Results:

Related Experiment Videos

  • Pharmacogenomic tests can identify patient subgroups likely to respond to specific treatments, optimizing medication selection.
  • The pharmaceutical industry can leverage these tests for clinical trial recruitment, data interpretation, and accelerating new drug development, potentially reducing late-stage failures.

Conclusions:

  • Pharmacogenomics holds significant potential for improving patient outcomes, reducing side effects, and lowering healthcare expenditures.
  • Despite its promise, the widespread availability and clinical impact of pharmacogenomic tests are currently limited, with ongoing evaluation needed for future healthcare integration.